ContractXponent Data License Agreement • August 14th, 2003 • Dendrite International Inc • Services-prepackaged software • Pennsylvania
IMS HEALTH INCORPORATED Restated Xponent Data License Agreement AGREEMENT, dated as of this 26th day of April, 2001, with an effective date of September 1, 2000 (“Effective Date”) by and between IMS Health Incorporated (hereinafter “IMS”), a Delaware corporation with an address at 200 Nyala Farms, Westport, Connecticut 06880, and the Interactive Marketing Division of Synavant Inc., (formerly known as Clark O’Neill) (hereinafter “Licensee”), a Delaware corporation, with an address at One Broad Avenue, Fairview, New Jersey 07022. This Agreement supercedes the Xponent Data License Agreement signed on August 31, 2000. RECITALS WHEREAS, IMS is principally engaged in providing information services to the pharmaceutical industry and, in connection therewith, collects data from pharmacies through various third parties relating to prescription transactions and prescribers; WHEREAS, Licensee on behalf of its customers, is principally engaged in providing direct marketing of pharmaceutical promot
ContractXponent Data License Agreement • August 18th, 2003 • Dendrite International Inc • Services-prepackaged software
Amendment To Restated Xponent Data License Agreement Dated April 26, 2001 Between IMS Health Incorporated And Interactive Marketing Division of Synavant, Inc. This amendment (“Amendment”), effective as of June 16, 2003 (the “Effective Date”), is entered into by and among IMS Health Incorporated (“IMS”), Synavant, Inc. (“Licensee”), and Dendrite International, Inc. (“Dendrite”) and supplements, modifies and is hereby made part of the Restated Xponent Data License Agreement dated April 26, 2001, with an effective date of September 1, 2000, as amended by an Addendum and Amendment to such agreement dated September 1, 2002, (the “Agreement”) between IMS and Licensee. 1. Background Licensee has agreed to be acquired by Dendrite and/or certain of its affiliates (such acquisition hereinafter referred to as the “Transaction”). In connection with the Transaction, the parties, by a letter agreement dated May 8, 2003 (the “Extension Agreement”) agreed to enter into an extension of the Agreement o
